PAM
BLRX

PVG Asset Management’s BioLineRX BLRX Stock Holding History

PVG Asset Management’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,930
Closed -$84.3K – 51
2024
Q3 		$84.3K Buy
3,930
+840
+27% +$23.1K 0.34% 39
2024
Q2 		$70.4K Buy
+3,090
New +$82.9K 0.28% 35
2023
Q4 		$97.1K Buy
+1,546
New +$95.6K 0.47% 29
2023
Q3 		– Sell
-1,546
Closed -$98.6K – 29
2023
Q2 		$98.6K Sell
1,546
-1,672
-52% -$92.6K 0.43% 31
2023
Q1 		$114K Buy
+3,218
New +$84.6K 0.37% 31
2022
Q4 		– Sell
-1,197
Closed -$44.3K – 39
2022
Q3 		$44.3K Buy
+1,197
New +$68.3K 0.17% 31
2021
Q4 		$327K Buy
4,009
+2,096
+110% +$218K 1.2% 20
2021
Q3 		$210K Buy
+1,913
New +$227K 0.63% 31

Other funds holding BLRX

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $192M AUM 24.96% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
OGF
Orin Green Financial San Diego, California $271M AUM 20.78% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

PVG Asset Management's BLRX Position: Q4 2024 in Review

PVG Asset Management sold out of BioLineRX (BLRX) in Q4 2024, closing a stake of 3,930 shares — an estimated $84.3K sold.

PVG Asset Management first reported a position in BLRX in Q3 2021 and held it in 8 quarters. The position peaked at $327K in Q4 2021. 31 funds tracked by Wall St. Rank hold BLRX as of Q4 2024.

  • PVG Asset Management reported no remaining BioLineRX position as of Q4 2024 after selling out during the quarter.
  • PVG Asset Management sold 3,930 BioLineRX shares in Q4 2024, an estimated $84.3K.
  • PVG Asset Management first reported a position in BioLineRX in Q3 2021 and held it in 8 quarters.
  • PVG Asset Management's BioLineRX position peaked at $327K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held BioLineRX as of Q4 2024.

Based on PVG Asset Management's 13F filing for Q4 2024, filed 21 Feb 2025.